Literature DB >> 33679788

Asymptomatic Herpes Simplex Virus Type 1 Infection Causes an Earlier Onset and More Severe Experimental Autoimmune Encephalomyelitis.

Luisa F Duarte1,2, María J Altamirano-Lagos1,2, Jorge H Tabares-Guevara1,2, Ma Cecilia Opazo1,3, Máximo Díaz1,3, Romina Navarrete1,2, Catalina Muza1,2, Omar P Vallejos1,2, Claudia A Riedel1,3, Susan M Bueno1,2, Alexis M Kalergis1,2,4, Pablo A González1,2.   

Abstract

Multiple sclerosis (MS) is an increasingly prevalent progressive autoimmune and debilitating chronic disease that involves the detrimental recognition of central nervous system (CNS) antigens by the immune system. Although significant progress has been made in the last decades on the biology of MS and the identification of novel therapies to treat its symptoms, the etiology of this disease remains unknown. However, recent studies have suggested that viral infections may contribute to disease onset. Interestingly, a potential association between herpes simplex virus type 1 (HSV-1) infection and MS has been reported, yet a direct relationship among both has not been conclusively demonstrated. Experimental autoimmune encephalomyelitis (EAE) recapitulates several aspects of MS in humans and is widely used to study this disease. Here, we evaluated the effect of asymptomatic brain infection by HSV-1 on the onset and severity of EAE in C57BL/6 mice. We also evaluated the effect of infection with an HSV-1-mutant that is attenuated in neurovirulence and does not cause encephalitis. Importantly, we observed more severe EAE in mice previously infected either, with the wild-type (WT) or the mutant HSV-1, as compared to uninfected control mice. Also, earlier EAE onset was seen after WT virus inoculation. These findings support the notion that a previous exposure to HSV-1 can accelerate and enhance EAE, which suggests a potential contribution of asymptomatic HSV-1 to the onset and severity of MS.
Copyright © 2021 Duarte, Altamirano-Lagos, Tabares-Guevara, Opazo, Díaz, Navarrete, Muza, Vallejos, Riedel, Bueno, Kalergis and González.

Entities:  

Keywords:  HSV-1; experimental autoimmune encephalomyelitis; multiple sclerosis; neuroinflammation; viral infection

Year:  2021        PMID: 33679788      PMCID: PMC7928309          DOI: 10.3389/fimmu.2021.635257

Source DB:  PubMed          Journal:  Front Immunol        ISSN: 1664-3224            Impact factor:   7.561


  64 in total

1.  Latent virus infection upregulates CD40 expression facilitating enhanced autoimmunity in a model of multiple sclerosis.

Authors:  Costanza Casiraghi; Ana Citlali Márquez; Iryna Shanina; Marc Steven Horwitz
Journal:  Sci Rep       Date:  2015-09-10       Impact factor: 4.379

2.  Detection of herpes simplex virus type 1 DNA sequences in normal and Alzheimer's disease brain using polymerase chain reaction.

Authors:  G A Jamieson; N J Maitland; J Craske; G K Wilcock; R F Itzhaki
Journal:  Biochem Soc Trans       Date:  1991-04       Impact factor: 5.407

3.  Molecular evidences for a role of HSV-1 in multiple sclerosis clinical acute attack.

Authors:  P Ferrante; R Mancuso; E Pagani; F R Guerini; M G Calvo; M Saresella; L Speciale; D Caputo
Journal:  J Neurovirol       Date:  2000-05       Impact factor: 2.643

4.  Neutrophils mediate blood-spinal cord barrier disruption in demyelinating neuroinflammatory diseases.

Authors:  Benoit Aubé; Sébastien A Lévesque; Alexandre Paré; Émilie Chamma; Hania Kébir; Roser Gorina; Marc-André Lécuyer; Jorge I Alvarez; Yves De Koninck; Britta Engelhardt; Alexandre Prat; Daniel Côté; Steve Lacroix
Journal:  J Immunol       Date:  2014-07-21       Impact factor: 5.422

5.  IL-6 detection in multiple sclerosis brain.

Authors:  D Maimone; G C Guazzi; P Annunziata
Journal:  J Neurol Sci       Date:  1997-02-27       Impact factor: 3.181

6.  Characterization of relapsing-remitting and chronic forms of experimental autoimmune encephalomyelitis in C57BL/6 mice.

Authors:  Jennifer L Berard; Kevin Wolak; Sylvie Fournier; Samuel David
Journal:  Glia       Date:  2010-03       Impact factor: 7.452

7.  KIR2DL2 inhibitory pathway enhances Th17 cytokine secretion by NK cells in response to herpesvirus infection in multiple sclerosis patients.

Authors:  Roberta Rizzo; Daria Bortolotti; Enrico Fainardi; Valentina Gentili; Silvia Bolzani; Eleonora Baldi; Ilaria Casetta; Enrico Granieri; Antonella Rotola; Roberto Furlan; Dario Di Luca
Journal:  J Neuroimmunol       Date:  2016-03-18       Impact factor: 3.478

8.  In active relapsing-remitting multiple sclerosis, effector T cell resistance to adaptive T(regs) involves IL-6-mediated signaling.

Authors:  Anya Schneider; Sarah Alice Long; Karen Cerosaletti; Chester T Ni; Peter Samuels; Mariko Kita; Jane Hoyt Buckner
Journal:  Sci Transl Med       Date:  2013-01-30       Impact factor: 17.956

Review 9.  Herpesvirus: an underestimated virus.

Authors:  Daniele Zendrini Rechenchoski; Ligia Carla Faccin-Galhardi; Rosa Elisa Carvalho Linhares; Carlos Nozawa
Journal:  Folia Microbiol (Praha)       Date:  2016-11-17       Impact factor: 2.629

Review 10.  The Emerging Role of Neutrophil Granulocytes in Multiple Sclerosis.

Authors:  Tonia Woodberry; Sophie E Bouffler; Alicia S Wilson; Rebecca L Buckland; Anne Brüstle
Journal:  J Clin Med       Date:  2018-12-03       Impact factor: 4.241

View more
  2 in total

1.  Mendelian Randomization Analysis Suggests No Associations of Herpes Simplex Virus Infections With Multiple Sclerosis.

Authors:  Wan Zhang; Pengfei Wu; Rui Yin; Meichen Sun; Rongsen Zhang; Xiaoyao Liao; Yuhong Lin; Hui Lu
Journal:  Front Neurosci       Date:  2022-03-01       Impact factor: 4.677

2.  Understanding global changes of the mouse brain proteome after vaginal infection with HSV-2 using a label-free shotgun approach.

Authors:  Jishuai Cheng; Qingzhen Wang; Yiwen Hu; Tangwei Mou; Jianbin Wang; Lichun Wang; Ying Zhang; Tinghua Wang; Qihan Li
Journal:  Front Cell Infect Microbiol       Date:  2022-08-18       Impact factor: 6.073

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.